Cargando…
Creating a standard inpatient opioid withdrawal protocol
Background: Despite safety and efficacy of medications for opioid use disorder, United States (US) hospitals face high health care costs when hospitalized patients with opioid use disorder (OUD) leave due to untreated opioid withdrawal. Recent studies have concluded that evidence-based intervention...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366550/ https://www.ncbi.nlm.nih.gov/pubmed/37496831 http://dx.doi.org/10.12688/mep.17533.1 |
_version_ | 1785077190732283904 |
---|---|
author | Abid, Ariana Shoptaw, Steve Bholat, Michelle |
author_facet | Abid, Ariana Shoptaw, Steve Bholat, Michelle |
author_sort | Abid, Ariana |
collection | PubMed |
description | Background: Despite safety and efficacy of medications for opioid use disorder, United States (US) hospitals face high health care costs when hospitalized patients with opioid use disorder (OUD) leave due to untreated opioid withdrawal. Recent studies have concluded that evidence-based interventions for OUD like buprenorphine are underutilized by hospital services. Objective: We developed a practical opioid withdrawal protocol utilizing buprenorphine and the Clinical Opiate Withdrawal Scale to address opioid withdrawal during inpatient treatment of a primary medical condition. We are currently implementing this protocol at the UCLA hospital in Santa Monica. Design: The protocol includes order sets with appropriate and modifiable orders that can be submitted in the electronic medical record in order to deliver seamless care for opioid withdrawal. After the physician assesses the patient and initiates the protocol, nursing provides an essential role in continuing to monitor the patient’s level of withdrawal and administering the appropriate medications in response. Inpatient pharmacy is instrumental in monitoring medication administration, as well as calculating and providing dosages for orders on Day 2 and 3 of the protocol. Collaboration with case managers is essential for providing appropriate resources and ensuring a safe discharge. Conclusion: Current challenges to widespread implementation of a standardized withdrawal protocol are discrepancies in addiction education across medical disciplines and inadequate outpatient access to buprenorphine providers and pharmacies that carry buprenorphine supplies. |
format | Online Article Text |
id | pubmed-10366550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-103665502023-07-26 Creating a standard inpatient opioid withdrawal protocol Abid, Ariana Shoptaw, Steve Bholat, Michelle MedEdPublish (2016) Open Letter Background: Despite safety and efficacy of medications for opioid use disorder, United States (US) hospitals face high health care costs when hospitalized patients with opioid use disorder (OUD) leave due to untreated opioid withdrawal. Recent studies have concluded that evidence-based interventions for OUD like buprenorphine are underutilized by hospital services. Objective: We developed a practical opioid withdrawal protocol utilizing buprenorphine and the Clinical Opiate Withdrawal Scale to address opioid withdrawal during inpatient treatment of a primary medical condition. We are currently implementing this protocol at the UCLA hospital in Santa Monica. Design: The protocol includes order sets with appropriate and modifiable orders that can be submitted in the electronic medical record in order to deliver seamless care for opioid withdrawal. After the physician assesses the patient and initiates the protocol, nursing provides an essential role in continuing to monitor the patient’s level of withdrawal and administering the appropriate medications in response. Inpatient pharmacy is instrumental in monitoring medication administration, as well as calculating and providing dosages for orders on Day 2 and 3 of the protocol. Collaboration with case managers is essential for providing appropriate resources and ensuring a safe discharge. Conclusion: Current challenges to widespread implementation of a standardized withdrawal protocol are discrepancies in addiction education across medical disciplines and inadequate outpatient access to buprenorphine providers and pharmacies that carry buprenorphine supplies. F1000 Research Limited 2022-02-04 /pmc/articles/PMC10366550/ /pubmed/37496831 http://dx.doi.org/10.12688/mep.17533.1 Text en Copyright: © 2022 Abid A et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Open Letter Abid, Ariana Shoptaw, Steve Bholat, Michelle Creating a standard inpatient opioid withdrawal protocol |
title | Creating a standard inpatient opioid withdrawal protocol |
title_full | Creating a standard inpatient opioid withdrawal protocol |
title_fullStr | Creating a standard inpatient opioid withdrawal protocol |
title_full_unstemmed | Creating a standard inpatient opioid withdrawal protocol |
title_short | Creating a standard inpatient opioid withdrawal protocol |
title_sort | creating a standard inpatient opioid withdrawal protocol |
topic | Open Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366550/ https://www.ncbi.nlm.nih.gov/pubmed/37496831 http://dx.doi.org/10.12688/mep.17533.1 |
work_keys_str_mv | AT abidariana creatingastandardinpatientopioidwithdrawalprotocol AT shoptawsteve creatingastandardinpatientopioidwithdrawalprotocol AT bholatmichelle creatingastandardinpatientopioidwithdrawalprotocol |